PAND - Pandion Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Pandion Therapeutics's activity chart (see below) currently has 1 price targets and 2 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 195 days.

Most recent stock forecast was given by GEOFFREY PORGES from LEERINK on 26-Feb-2021. First documented stock forecast 11-Aug-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Aug-2020

$24

5 years 7 months 6 days ago
(26-Feb-2021)

1/1 (100%)

$5.15 (27.32%)

195

Show more analysts

What is PAND (Pandion Therapeutics) average time for price targets to be met?

On average it took 195 days for the stock forecasts to be reached, with an average price target met ratio of 100%.

Which analyst most recently updated their price target on PAND (Pandion Therapeutics)?

Geoffrey Porges

Which analyst has the most public recommendations on PAND (Pandion Therapeutics)?

Geoffrey Porges works at LEERINK and has 42 price targets and 26 ratings on PAND

Which analyst is the currently most bullish on PAND (Pandion Therapeutics)?

Geoffrey Porges with the highest potential upside of $0

Which analyst is the currently most reserved on PAND (Pandion Therapeutics)?

Geoffrey Porges with the lowest potential downside of -$0